From: Heart rate variability and target organ damage in hypertensive patients
Characteristic | Value |
---|---|
Age (years) | 62.5 ± 12.1 |
Sex (male/female, %) | 63.5/36.5 |
Family history of hypertension (yes/no, %) | 56.5/43.5 |
Family history of stroke (yes/no, %) | 19.5/80.5 |
Smokers (yes/ex/no, %) | 17.5/21/61.5 |
Diabetes (yes/no, %) | 10/90 |
Diastolic BP (mmHg) | 75.6 ± 12.0 |
Systolic BP (mmHg) | 133.2 ± 22.6 |
Pulse pressure (mmHg) | 57.6 ± 17.8 |
Fasting blood glucose (mmHg) | 102.7 ± 24.1 |
Total Cholesterol (mg/dl) | 185.8 ± 40.6 |
BMI (kg/m2) | 27.7 ± 4.6 |
Beta-blockers (yes/no, %) | 33.5/66.5 |
Alphabeta-blockers (yes/no, %) | 10.5/89.5 |
Alpha-blockers (yes/no, %) | 8/92 |
Diuretics (yes/no, %) | 43.5/56.5 |
ACE inhibitor (yes/no, %) | 37.5/62.5 |
Dihydropyridine (yes/no, %) | 26/74 |
eGFR (mL/min/1.73 m2) | 77.0 ± 18.9 |
Kidney Involvement (group 1/ 2 /3 %) | 24/59.5/16.5 |
IMT (mm) | 2.24 ± 1.56 |
Vascular abnormalities (no/ thickening/plaque, %) | 13/11/78 |
LVMi g/m2 | 130.5 ± 31.0 |
Left Ventricular hypertrophy (no/yes, %) | 40/60 |